메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Infinitus' "Better Health for 10,000 Households" Initiative Named Among China's "Four 100s" Top Volunteer Service Projects

Strengthening Community Wellness and Supporting the Healthy China Initiative GUANGZHOU, China, Sept. 9, 2025 -- A nationwide, government-led panel—organized by the Social Work Department of the CPC Central Committee in collaboration with 21 other agencies—has released the 2024 "Four 100s" list recognizing exemplary volunteer service efforts. "Better Health for 10,000 Households" initiated in Guangdong by Infinitus (China) Company Ltd. (hereafter as Infinitus) was selected as one of the "Top Volunteer Service Projects." The achievement reflects the Company'
- 김갑성 기자
- 2025-09-09 18:46
Dizal Showcases Robust Portfolio of Lung Cancer Studies at 2025 WCLC

SHANGHAI, Sept. 9, 2025 -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced the presentation of new findings on its leading assets, ZEGFROVY® (sunvozertinib) and golidocitinib, in non-small cell lung cancer (NSCLC) at the 2025 World Conference on Lung Cancer (WCLC), held September 6–9 in Barcelona, Spain. ZEGFROVY: Targeting EGFR exon20ins and a wide spectrum of EGFR mutations The latest data from the multinational pivotal WU-KONG1 Part B (WU-KONG1B)
- 김갑성 기자
- 2025-09-09 18:00
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry

[ 메디채널 김갑성 기자 ] End-to-end Green CRDMO solutions to enable global clients for broader positive impact Span from biologics research, development, manufacturing, and overall operations Integration with lean management and digitalization for continuous excellence A comprehensive ecosystem featuring diverse energy-saving and carbon-reduction initiatives SHANGHAI, Sept. 9, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently launched the "WuXi Biologics Green CRDMO White Paper" at its first CR
- 김갑성 기자
- 2025-09-09 18:00
World-Renowned Artist Liu Bolin Unveils Three Singapore Works in Support of Persons living with Rare Disorders

Canvas of Hope is slated to launch this weekend with new artworks exploring visibility and advocacy; The Rare Gallery opens 14 September 2025 with charity art gala dinner set for 28 March 2026 SINGAPORE, Sept. 9, 2025 -- Internationally acclaimed Chinese contemporary artist Liu Bolin, widely known as the "Invisible Man" for his thought-provoking camouflage performances, has unveiled three new Singapore-themed artworks under the Canvas of Hope initiative — a collaboration with the Rare Disorders Society (Singapore) [RDSS]. His live art creations, already underwa
- 김장윤(JASON KIM) 기자
- 2025-09-09 15:29
Bayer Foundation Backs 15 Women Entrepreneurs Scaling Urgent Healthcare and Food Solutions

LEVERKUSEN, Germany, Sept. 9, 2025 -- The Bayer Foundation Women Entrepreneurs Award (BFWEA), powered by the Impact Hub Network, honours 15 women from Latin America, Africa & the Middle East, and Asia Pacific who are addressing critical challenges in healthcare and food security. According to reports by the United Nations and World Health Organisation, nearly 295 million people globally face acute hunger and 2.33 billion live with food insecurity. Against this backdrop, practical, scalable solutions are needed more urgently than ever. Selected from 1,763 applicants
- 김갑성 기자
- 2025-09-09 15:00
LISCure BioSciences Secures World's First FDA NDI notification for Hair Health Probiotic Mobiome®

SEOUL, South Korea, Sept. 9, 2025 -- LISCure BioSciences ("LISCure") today announced that Mobiome®, its proprietary hair health probiotic, has received New Dietary Ingredient (NDI) Notification from the U.S. Food and Drug Administration (FDA) —the first such recognition worldwide for targeting hair health. Mobiome® had previously been approved by the Korean Ministry of Food and Drug Safety (MFDS) as a new functional ingredient, based on extensive scientific validation in both preclinical and clinical studies. Results demonstrated multiple mechanisms of action, includi
- 김갑성 기자
- 2025-09-09 13:41
Leaft Foods Partners with Lacto Japan to Introduce Revolutionary Leaf Rubisco Protein to Japanese Market

[ 메디채널 김갑성 기자 ] Strategic partnership leverages Lacto's market expertise to bring next-generation protein to Japan's innovation-driven food manufacturers ROLLESTON, New Zealand and TOKYO, Sept. 9, 2025 -- Leaft Foods, a company that harnesses the planet's most plentiful protein extracted directly from green leaves to make industry-defining products, today announced a strategic partnership with Lacto Japan Co., Ltd., a leading distributor and producer of specialty food ingredients. The collaboration will accelerate the commercialization of Leaft's groundbreaking Rubisco Protein Isola
- 김갑성 기자
- 2025-09-09 11:01
SWISS REJU wins prestigious HK01 Award for the second consecutive year, continues dedication with AI leadership

HONG KONG, Sept. 9, 2025 -- SWISS REJU, a recognized luxury beauty boutique, announced today that it has again been named as the Winner in the HK01 Annual Lifestyle Awards. HK01 is one of Hong Kong's most popular news outlets and lifestyle media platforms. This year's HK01 Lifestyle Awards highlight top companies that deliver outstanding services, leadership, and positive social impact. These prestigious Awards are presented to top performing companies across major sectors. Among the Winners this year are KEETA, GO PARK, Nestle and CSL, winners reflect the very best of what top performing bra
- 김갑성 기자
- 2025-09-09 10:00
Elevating Healthcare Innovation: ICP DAS-BMP Brings Advanced TPU Portfolio at Medtec China 2025

HSINCHU, Sept. 9, 2025 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in Medtec China 2025, to be held from September 24 to 26 at the Shanghai World Expo Exhibition & Convention Center. The spotlight of this year's exhibit will be the low-migration ARP-B20 TPU, developed to meet ISO 10993 biocompatibility standards and suitable for 90-day implant applications. Low-migration TPU significantly reduces additive migration during the heat-setting pr
- 김갑성 기자
- 2025-09-09 09:45
의료 혁신의 도약: ICP DAS-BMP, 메디텍 차이나 2025에서 첨단 TPU 포트폴리오 공개

신주 2025년 9월 9일 -- 대만에 본사를 둔 의료용 TPU(열가소성 폴리우레탄)의 제조 및 공급업체인 ICP DAS-BMP(Biomedical Polymers)가 9월 24일부터 26일까지 상하이 세계엑스포전시컨벤션센터(Shanghai World Expo Exhibition & Convention Center )에서 개최되는 메디텍 차이나 2025(Medtec China 2025)에 참가한다고 발표했다. 올해 전시회의 핵심 제품은 내이행성 ARP-B20 TPU로, ISO 10993 생체 적합성 표준을 충족하며 90일간의 체내 이식 분야에 적합하도록 개발됐다. 내이행성 TPU는 열 고정 공정 중 첨가제 이동을 크게 줄여 카테터가 사용 기간 내내 깨끗하고 매끄러운 표면을 유지하도록 돕는다. 15가지 색상 옵션을 제공해 설계 유연성을 높였으며, 특정 임상 요구에 맞는 맞춤형 솔루션 구현이 가능하다. ICP DAS-BMP는 또한 다양한 의료 분야에 활용할 수 있는 다양한 TPU 소재를 선보인다. 기본 Arothane™, Alithane™, Durathane™ TPU(ARP/ALP/ALC 시리즈)는
- 김갑성 기자
- 2025-09-09 09:45

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2025-11-05_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 07시 20분